Blog

Please note most of these publications were published by our predecessor company CellPoint, LLC.

Cancer Imaging

Targeting the Hexosamine Biosynthetic Pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma

Oncotarget, Advance Publications 2016 https://celltheranostics.com/wp-content/uploads/2019/11/12413-186535-1-PB-2016-EC-G-Paper.pdf

Read

Cell>Point Announces Postive Results from 99mTc-Oncardia® (EC- G) trial at the Unviersity of Chicago Medical Center to image and montior therapy for Head and Neck Cancer.

CENTENNIAL, Colo., January 15, 2015 – Cell>Point announced today positive results following conclusion of a Head and Neck…

Read

Patched Targeted Peptides for Imaging and Treatment of Hedgehog Positive Breast Tumors

Published: September 2014, Bio Medical Research International https://celltheranostics.com/wp-content/uploads/2019/11/Patched-Targeting-Peptides-for-Imaging-and-Treatment-of-Hedgehog-Postive-Breast-Tumors.pdf

Read

Cell>Point and HYUN IMC Expand License in South Korea to Include Hanmi Pharmaceutical, Co., Ltd for Cancer and Heart Disease Imaging

Third License Completes the Company’s Initiative to Secure a Strong Pharmaceutical  Partner for the South Korean Market CENTENNIAL, Colo.,…

Read

Development of 99mTc-EC-tyrosine for Early Detection of Breast Cancer Tumor Response to the Anticancer Drug Melphalan

Published: January 2013, Vol. 20, No. 1, Academic Radiology https://celltheranostics.com/wp-content/uploads/2019/11/Deveopment-of-99mTc-EC-tyrosine-for-Early-Detection-of-Breast-Cancer-Tumror-Response-to-the-Anticancer-Drug-Melphalan.pdf

Read

Cell>Point Announces Agreement with the FDA on a Special Protocol Assessment for the Phase 3 Technetium-99m-EC-G Lung Cancer Imaging Trial

CENTENNIAL, Colo., March 8, 2012 – Cell>Point, L.L.C , announced today that it received a letter from the…

Read

Cell>Point Executes Asia License with HYUN IMC for Cancer and Heart Disease Diagnostic Imaging Agent, Technetium-99m-EC-G

CENTENNIAL, Colo., February 28, 2012 – Cell>Point announced today that it had entered into a licensing agreement for…

Read

Synthesis of 99mTc-EC-AMT as a imaging probe for amino acid transporter sytems in breast cancer

Published: 2010, Vol. 31, No. 8, Nuclear Medicine Communications https://celltheranostics.com/wp-content/uploads/2019/11/Synthesis-of-99mTc-EC-AMT-as-an-imaging-probe-for-amino-acid-transporter-systems-in-breast-cancer.pdf 

Read

Radiation dosimetry and biodistribution of 99mTc-ethylenedicysteine-deoxyglucose in patients with non-small-cell lung cancer.

European Journal Nuclear Medicine Molecular Imaging, 2009 https://celltheranostics.com/wp-content/uploads/2019/11/EC-DG-article-Phase-I.pdf

Read

Molecular imaging of Bcr-Abl phosphokinanse in a xenograft model

Published: March 3, 2009, Molecular Cancer Therapeutics https://celltheranostics.com/wp-content/uploads/2019/11/Molecular-imaging-of-Bcr-Abl-phosphokinanse-in-a-xenograft-model.pdf

Read

Technologies for Translational Imaging Using Generators in Oncology Short Running Title: Imaging and Oncology

Anti-Cancer Drug Discovery, 2007 https://celltheranostics.com/wp-content/uploads/2019/11/Schechter-MS.pdf

Read

Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals.

current medical imaging reviews 2004 https://celltheranostics.com/wp-content/uploads/2019/11/EC-GA-68-Jan-2005.pdf  

Read